0001876405-21-000001.txt : 20211202
0001876405-21-000001.hdr.sgml : 20211202
20211202113836
ACCESSION NUMBER: 0001876405-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(1)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20211202
DATE AS OF CHANGE: 20211202
EFFECTIVENESS DATE: 20211202
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACORN BIOVENTURES 2, L.P.
CENTRAL INDEX KEY: 0001876405
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-423299
FILM NUMBER: 211465465
BUSINESS ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 2626
CITY: NEW YORK
STATE: NY
ZIP: 10170
BUSINESS PHONE: 212-299-4777
MAIL ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 2626
CITY: NEW YORK
STATE: NY
ZIP: 10170
D
1
primary_doc.xml
X0708
D
LIVE
0001876405
ACORN BIOVENTURES 2, L.P.
420 LEXINGTON AVENUE, SUITE 2626
NEW YORK
NY
NEW YORK
10170
212-299-4777
DELAWARE
None
None
Limited Partnership
true
2021
GENERAL PARTNER
ACORN CAPITAL ADVISORS GP 2, LLC
420 LEXINGTON AVENUE, SUITE 2626
NEW YORK
NY
NEW YORK
10170
Promoter
GENERAL PARTNER OF THE ISSUER
ANDERS
HOVE
420 LEXINGTON AVENUE, SUITE 2626
NEW YORK
NY
NEW YORK
10170
Promoter
MANAGING MEMBER OF THE GENERAL PARTNER OF THE ISSUER
Pooled Investment Fund
Venture Capital Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.1
- 3C.7
false
true
false
true
false
0
Indefinite
0
Indefinite
false
0
0
0
0
true
THE ISSUER'S GENERAL PARTNER, OR AN AFFILIATE OF THE
ISSUER'S GENERAL PARTNER, MAY BE ENTITLED TO RECEIVE
A MANAGEMENT FEE IN ACCORDANCE WITH THE ISSUER'S
GOVERNING DOCUMENTATION, AS AMENDED FROM TIME TO
TIME.
false
ACORN BIOVENTURES 2, L.P.
/S/ ANDERS HOVE
ANDERS HOVE
MANAGING MEMBER OF THE GENERAL PARTNER OF THE ISSUER
2021-12-02